The Pentagon Is Stockpiling and This Company Is Poised With a "Tier 1 Priority" Resource

America is racing to rebuild its domestic supply of strategic materials. One company with projects across key allied nations is in the right place at the right time.

Regeneron Pharmaceuticals, Inc
NASDAQ:REGN
$551.64
Open 546.67 Prev Close 547.93
High 554.00 Low 544.58
Volume 285,848 Volume (Avg) 1,306
52 Week High 1,207.86 52 Week Low 476.49
Market Cap 59.6B PE Ratio 14.04

General

NameRegeneron Pharmaceuticals, Inc
TickerREGN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees15,158

About Regeneron Pharmaceuticals, Inc

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia (HoFH) or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; Evkeeza for treatment of HoFH; Ordspono for Follicular lymphoma and Diffuse large B-cell lymphoma; and Veopoz for CD55-deficient protein-losing enteropathy. Further, it develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types; and with Sonoma Biotherapeutics, Inc. to discover, develop, and commercialize engineered regulatory T cell therapies. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Highlights

Analyst Target727.52
Market Cap59,558,100,000
PE Ratio14.04
PEG Ratio1.16
EBITDA4,471,000,064

Valuation

Trailing PE13.93
Forward PE15.29
Price/Sales (Trailing 12 Mt.)4.20
Price/Book (Most Recent Quarter)2.01

Technicals

Beta0.32
52 Week High1,207.86
52 Week Low476.49
50 Day Average1.30%
200 Day Average-20.22%

Dividend

Regeneron Pharmaceuticals, Inc pays out a dividend of $2.83 per share, with a dividend yield of 0.51%.

REGN's last dividend payment was made to shareholders on June 6, 2025.

They pay out 0.00% of their earnings out as a dividend.

Recent Dividends

Jun 6, 2025$0.88
Mar 20, 2025$0.88
Most Popular

Nvidia Is 'On A March To $5 Trillion' Market Capitalization, Says Dan Ives As He Predicts Bullish Environment For Tech And Crypto: 'Very Strong Second Half'

Wedbush analyst Daniel Ives delivered an optimistic outlook for Nvidia Corp. (NASDAQ:NVDA) and the broader tech and crypto markets, predicting a $5 trillion market capitalization for the tech giant led by Jensen Huang.

Copper's Spiking - And This Junior Has the Grades to Match - Ad

Copper is climbing again - and this time, it looks tariff-proof. A $31M junior just posted nearly 1B lbs of copper equivalent. With insiders and institutions piling in, this could be the next breakout.

Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not

WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.

Cantor Equity Partners I (CEPO) Soars On Potential Bitcoin Deal With Satoshi Nakamoto-Linked Adam Back

Shares of special purpose acquisition company Cantor Equity Partners I Inc (NASDAQ:CEPO) surged into the close on Tuesday following a report that the company is nearing a deal to invest billions in Bitcoin (CRYPTO:

Robotics Meets Public Safety Innovation - Ad

Advanced security robots, real-world impact, and a valuation gap too big to ignore. This robotics stock is one to watch.

Citi Sees 30% Upside In Circle Stock, Backs USDC Issuer As Key Player In Stablecoin Market

Circle Internet Group Inc. (NYSE:CRCL), the issuer behind USDC (CRYPTO: USDC), has been a standout in the stock market this year, and the latest endorsement from Citigroup Inc. (NYSE:

Robinhood Just Made Crypto Simpler — And Way More Powerful

Robinhood Markets (NASDAQ:HOOD) has made a significant push into crypto, unveiling a suite of inno

Trump's Fast-Track Plan: These 3 Stocks Are Set to Soar - Ad

AI isn't the only game-changer on Wall Street right now. President Trump is fast-tracking a select group of U.S. companies-quietly accelerating their growth and profit potential. According to legendary investor Louis Navellier, this move could ignite a massive stock surge...And he's identified three companies that stand to benefit most.

Asian shares mostly decline as worries continue over Trump's tariffs

TOKYO (AP) — Asian shares were mostly lower in early Tuesday trading, as worries about President Donald Trump’s latest weighed on investor sentiments.

How Trump could use a building renovation to oust the Fed chair

WASHINGTON (AP) — President says he has finally found a way to achieve his goal of removing Federal Reserve Chair Jerome Powell, accusing him of mismanaging the U.S. central bank’s $2.5 billion renovation project.

The Robotics Underdog Ready to Run - Ad

An AI robotics company cutting crime by 46% and scaling fast-yet its valuation lags behind peers.

T. Rowe Price: Why Shares Could See Prolonged Underperformance

T. Rowe Price stock has entered the final phase of its Adhishthana Cycle, signaling potential long-term underperformance as structural weakness sets in.

Rescuers search for survivors after Houthi attack on cargo ship in the Red Sea

DUBAI, United Arab Emirates (AP) — Rescuers launched a search Wednesday for survivors of a Liberian-flagged cargo ship that came under attack from in the Red Sea, authorities said. At least three mariners were killed and two were wounded.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Trump asks Supreme Court to remove 3 Democrats on the Consumer Product Safety Commission

WASHINGTON (AP) — The Trump administration on Wednesday asked the to remove three Democratic members of the , who were fired by President and then reinstated by a federal judge.

Amy Coney Barrett Earns Trump's Credit After Court Ruling: 'I Have Great Respect For Her'

Trump praises Justice Barrett's Supreme Court ruling limiting nationwide injunctions, while blasting NYC's Mamdani and defending his economic agenda.

Gold Just Hit Another Record. This Junior Could Be Next. - Ad

This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.

Paramount to pay $16 million in settlement with Trump over '60 Minutes' interview

In a case seen as a challenge to free speech, Paramount has agreed to pay $16 million to settle a lawsuit filed by President Donald Trump over the editing of CBS' “60 Minutes” interview with then-Vice President Kamala Harris in October.

Elon's Greatest Invention... Hidden in South Memphis? - Ad

In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.

Greenland has a message for the rest of the world: Come visit

NUUK, Greenland (AP) — has a message for the rest of the world: We’re waiting for you.

Robotics Valuation Gap: Who Will Win? - Ad

Two companies. Same sector. Vastly different valuations. One brings in millions in revenue, the other, barely a fraction. The market hasn't caught on yet.

FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff

WASHINGTON (AP) — The working under Health Secretary recently of two COVID-19 vaccines, disregarding recommendations from government scientists, according to federal documents released Wednesday.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

NIO Breaks Tradition, Repositions Key Event To Align With SUV Debut

NIO stock edges higher as the company reschedules NIO Day 2025 and reports strong June deliveries.

The Pentagon Is Stockpiling and This Company Is Poised With a "Tier 1 Priority" Resource - Ad

America is racing to rebuild its domestic supply of strategic materials. One company with projects across key allied nations is in the right place at the right time.

US brings charges in North Korean remote worker scheme that officials say funds weapons program

WASHINGTON (AP) — The Justice Department announced criminal charges Monday in connection with a scheme by North Korea to fund its weapons program through the salaries of remote information technology workers employed unwittingly by U.S. companies.

Copper's Spiking - And This Junior Has the Grades to Match - Ad

Copper is climbing again - and this time, it looks tariff-proof. A $31M junior just posted nearly 1B lbs of copper equivalent. With insiders and institutions piling in, this could be the next breakout.

Elon Musk Renews Demand for Jeffrey Epstein Files Release, Weeks After Alleging Trump Is Named in Them

Elon Musk has once again demanded the release of the unredacted Jeffrey Epstein files. This comes in the wake of his allegations against President Trump.

ProKidney Stock Shoots Up Over 8% After Hours After Staggering 515% Rally On Wednesday

ProKidney (NASDAQ: PROK) experienced a surge of 515% during Tuesday's trading session and gained additional 8.58% after-hours to $4.05 on positive Phase 2 trial results, with trading volume seeing a jump to 39.8 million shares from an average of 1.12 million.

Robotics Meets Public Safety Innovation - Ad

Advanced security robots, real-world impact, and a valuation gap too big to ignore. This robotics stock is one to watch.

Ex-Trump Family Attorney Raises Alarms Over Trump's Actions as President: 'I Have Never Been As Concerned'

Abbe Lowell expressed serious concerns about the potential harm that the current administration could cause to the country's institutions.

Trump's Fast-Track Plan: These 3 Stocks Are Set to Soar - Ad

AI isn't the only game-changer on Wall Street right now. President Trump is fast-tracking a select group of U.S. companies-quietly accelerating their growth and profit potential. According to legendary investor Louis Navellier, this move could ignite a massive stock surge...And he's identified three companies that stand to benefit most.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright smartmoneytrading.net
Privacy Policy | Terms of Service